HOME ABOUT US SCIENCE PIPELINE CAREERS NEWS & EVENTS CONTACT US RECENT NEWS 1 October 2012Innovimmune profiled in BioCentury as Emerging Company7 August 2012Innovimmune featured in Xconomy INNOVIMMUNE is a specialty Drug Discovery & Exploratory Development biotechnology company leading the d...

HOME ABOUT US SCIENCE PIPELINE CAREERS NEWS & EVENTS CONTACT US PIPELINE INV-17 PROGRAM INV-88 PROGRAM INV-17 PROGRAM T Helper 17 [TH17] cells and its production of signature TH17 cytokines interleukin [IL]-17A, IL-17F playa critical role in the pathogenesis of several autoimmune and immunoInfla...

HOME ABOUT US SCIENCE PIPELINE CAREERS NEWS & EVENTS CONTACT US RECENT NEWS 1 October 2012Innovimmune profiled in BioCentury as Emerging Company7 August 2012Innovimmune featured in Xconomy INNOVIMMUNE is a specialty Drug Discovery & Exploratory Development biotechnology company leading the d...

HOME ABOUT US SCIENCE PIPELINE CAREERS NEWS & EVENTS CONTACT US SCIENCE AUTOIMMUNE DISEASES & INFLAMMATION AUTOIMMUNE DISEASES & INFLAMMATION Innovimmunes target disease indications within our core specialty therapeutic areas are: Autoimmune & ImmunoInflammation Diseases Rheumatoid A...

HOME ABOUT US SCIENCE PIPELINE CAREERS NEWS & EVENTS CONTACT US SCIENCE AUTOIMMUNE DISEASES & INFLAMMATION SCIENCE There are high unmet medical needs in the few established immunomodulatory therapies for Innovimmunes core therapeutic areas within Autoimmune Diseases and Inflammation. The lim...